Assenagon Asset Management S.A.减持1,696,984股10x Genomics $TXG股份 - MarketBeat
Assenagon Asset Management S.A. Sells 1,696,984 Shares of 10x Genomics $TXG - MarketBeat
生命科学资讯
生物技术与制药领域的最新动态
弗里登塔尔金融公司新购入10x Genomics（TXG）股份 - MarketBeat
Friedenthal Financial Purchases New Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics（纳斯达克：TXG）股价下跌4.1%——该卖出吗？——MarketBeat
10x Genomics (NASDAQ:TXG) Trading Down 4.1% - Should You Sell? - MarketBeat
空间转录组学市场规模、趋势及至2034年增长报告 - Straits Research
Spatial Transcriptomics Market Size, Trends & Growth Report by 2034 - Straits Research
尽管研究支出不均，巴克莱对10x Genomics公司（TXG）转为更乐观态度 - MSN
Barclays turns more bullish on 10x Genomics, Inc. (TXG) despite uneven research spending - MSN
巴克莱对10x基因组学公司（TXG）转为更乐观态度，尽管研发支出不均——内部人士观察
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Insider Monkey
巴克莱对10x Genomics公司（TXG）转为更乐观态度，尽管研究支出不均——内幕猴子
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Insider Monkey
巴克莱对10x基因组学公司（TXG）更为乐观，尽管研究支出不均——雅虎财经
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Yahoo Finance
巴克莱对10x基因组学公司（TXG）转为更乐观态度，尽管研究支出波动——雅虎财经英国版
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Yahoo Finance UK
Canaccord Genuity维持10x Genomics (TXG)买入评级 - 纳斯达克
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - Nasdaq
10x Genomics (TXG) 股价上涨，原因如下 - Finviz
10x Genomics (TXG) Stock Trades Up, Here Is Why - Finviz
10x Genomics股票为何突然飙升——来自TipRanks的分析
Why 10x Genomics Stock Is Suddenly Surging - TipRanks
10x Genomics (TXG) 股价上涨，原因如下 - 雅虎财经
10x Genomics (TXG) Stock Trades Up, Here Is Why - Yahoo Finance
10x Genomics (TXG) 股价上涨，原因如下 - TradingView — 追踪所有市场动态
10x Genomics (TXG) Stock Trades Up, Here Is Why - TradingView — Track All Markets
10x Genomics (TXG) 股价上涨，原因如下 - FinancialContent
10x Genomics (TXG) Stock Trades Up, Here Is Why - FinancialContent
10x Genomics (TXG)维持买入评级，目标价上调至20美元 | TXG股票新闻 - GuruFocus
10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus
10x Genomics (TXG)维持买入评级，目标价上调至20美元 | TXG股票新闻 - GuruFocus
10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus
10x Genomics（纳斯达克股票代码：TXG）获Canaccord Genuity集团设定20美元新目标价 - MarketBeat
10x Genomics (NASDAQ:TXG) Given New $20.00 Price Target at Canaccord Genuity Group - MarketBeat
兰开斯特投资管理公司购入621,779股10x Genomics（TXG）股份 - MarketBeat
Lancaster Investment Management Purchases Shares of 621,779 10x Genomics $TXG - MarketBeat
10x Genomics Inc. 股票是否为避险资产 - 季度业绩总结与技术确认提醒 - DonanımHaber
Is 10x Genomics Inc. stock a safe haven asset - Quarterly Performance Summary & Technical Confirmation Alerts - DonanımHaber